GIORDANO, GIORGIA
 Distribuzione geografica
Continente #
NA - Nord America 109
EU - Europa 92
AS - Asia 23
OC - Oceania 2
AF - Africa 1
Totale 227
Nazione #
US - Stati Uniti d'America 109
IT - Italia 69
IE - Irlanda 12
SG - Singapore 10
SE - Svezia 7
CN - Cina 6
JP - Giappone 3
AU - Australia 2
IL - Israele 2
NO - Norvegia 2
FR - Francia 1
HK - Hong Kong 1
KR - Corea 1
MA - Marocco 1
NL - Olanda 1
Totale 227
Città #
Chandler 38
Turin 15
Dublin 12
Milan 12
Carrara 6
Singapore 6
Cagliari 5
Medford 5
Nyköping 5
Torino 4
Ashburn 3
Fairfield 3
Genoa 3
Hebei 3
Pocapaglia 3
Princeton 3
Bologna 2
Kawasaki 2
New York 2
Reggio Calabria 2
Reno 2
Rome 2
Settimo Torinese 2
Stavanger 2
Tampa 2
Udine 2
Wilmington 2
Amsterdam 1
Beijing 1
Boston 1
Cambridge 1
Chicago 1
Concesio 1
Hangzhou 1
Houston 1
Pasadena 1
Salé 1
San Diego 1
Seoul 1
Shanghai 1
Tappahannock 1
Tokyo 1
Upper Marlboro 1
Totale 164
Nome #
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination 83
Epha2 expression in bone sarcomas: Bioinformatic analyses and preclinical characterization in patient-derived models of osteosarcoma, ewing’s sarcoma and chondrosarcoma 56
Parp1 inhibitor and trabectedin combination does not increase tumor mutational burden in advanced sarcomas—a preclinical and translational study 50
Enhancing proteotoxic stress in leiomyosarcoma cells triggers mitochondrial dysfunctions, cell death, and antitumor activity in vivo 43
AI Based Discovery of a New AKR1C3 Inhibitor for Anticancer Applications 5
Comprehensive Molecular Profiling of NPM1-Mutated Acute Myeloid Leukemia Using RNAseq Approach 3
Totale 240
Categoria #
all - tutte 1.067
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.067


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202255 3 0 2 0 1 1 9 5 0 2 20 12
2022/2023105 7 4 3 9 10 32 7 9 12 2 4 6
2023/202472 9 21 1 6 2 8 5 1 1 4 11 3
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 240